NanoString to Release Second Quarter 2022 Operating Results and Host a Conference Call on Thursday, August 4, 2022



SEATTLE–(BUSINESS WIRE)– NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company will report its second quarter 2022 operating results following the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30 p.m. ET to discuss these results and provide a business update.

Investors and other interested parties should pre-register for the conference call by visiting After registration, a confirmation email will be sent with login details and unique conference call codes for entry. Registration is open throughout the call, but to ensure connection for the duration of the call, it is recommended to register in advance.

The link to the webcast and audio replay will be available on the Investor Relations website:

A replay of the call will be available from August 4, 2022 at 7:30 p.m. ET until midnight August 11, 2022. To access the replay, dial (866) 813-9403 or (929) 458-6194 and quote the conference ID. : 426771. The webcast will also be available on the Company’s website for one year after the call ends.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides platforms that allow researchers to map the universe of biology. The nCounter® analysis system, cited in over 6,000 peer-reviewed publications, provides a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with sensitivity and high precision. NanoString’s GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in approximately 90 peer-reviewed publications. The CosMx Spatial Molecular Imager, slated for commercial availability in the second half of 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells in morphologically whole tissue sections. intact.

For more information, please visit

See the source version on


Doug Farrel
Vice President, Investor Relations and Corporate Communications
[email protected]
Phone: 206-602-1768

Source: NanoString Technologies, Inc.

Powered by Business Wire

Read this press release online at:

Source link


Comments are closed.